Proprietary AI analyst is now available

Biome Australia Valuation Multiples

Discover revenue and EBITDA valuation multiples for Biome Australia and similar public comparables like Hofseth BioCare, Provexis, Enzymatica, Valbiotis and more.

Biome Australia Overview

About Biome Australia

Biome Australia Ltd licences, develops, and markets evidence-based, complementary medicines, including nutraceuticals vitamins and weight management products and live biotherapeutics. The company has one operating segment: researching, developing, manufacturing and distributing evidence-based products linking the gut and human health. Domestically it caters to Australia and In international markets, the Group distributes and markets its Activated Probiotics range in the United Kingdom and New Zealand through independent health practitioners.


Founded

2018

HQ

Australia

Employees

30

Financials (LTM)

Revenue: $18M
EBITDA: $3M

EV

$44M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Biome Australia Financials

Biome Australia reported last 12-month revenue of $18M and EBITDA of $3M.

In the same LTM period, Biome Australia generated $11M in gross profit, $3M in EBITDA, and $2M in net income.

Revenue (LTM)


Biome Australia P&L

In the most recent fiscal year, Biome Australia reported revenue of $13M and EBITDA of $454K.

Biome Australia is profitable as of last fiscal year, with gross margin of 61%, EBITDA margin of 3%, and net margin of 1%.

See analyst estimates for Biome Australia
LTMLast FY202320242025202620272028
Revenue$18M$13M$7M$11M$16M
Gross Profit$11M$8M$4M$7M$10M
Gross Margin62%61%60%61%62%
EBITDA$3M$454K($1M)($225K)$2M
EBITDA Margin15%3%(20%)(2%)10%
EBIT Margin14%1%(26%)(6%)8%
Net Profit$2M$152K($2M)($514K)$1M
Net Margin13%1%(23%)(5%)8%
Net Debt-$112K---

Financial data powered by Morningstar, Inc.

Biome Australia Stock Performance

Biome Australia has current market cap of $45M, and enterprise value of $44M.

Market Cap Evolution


Biome Australia's stock price is $0.20.

Biome Australia share price increased by 18.1% in the last 30 days, and decreased by 38.4% in the last year.

See more trading valuation data for Biome Australia
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$44M$45M-0.1%18.1%-14.8%-38.4%$0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Biome Australia Valuation Multiples

Biome Australia trades at 2.5x EV/Revenue multiple, and 16.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Biome Australia

EV / Revenue (LTM)


Biome Australia Financial Valuation Multiples

As of June 18, 2026, Biome Australia has market cap of $45M and EV of $44M.

Biome Australia has a P/E ratio of 19.4x.

LTMLast FY202320242025202620272028
EV/Revenue2.5x3.4x6.2x4.0x2.9x
EV/EBITDA16.6x97.9x(31.1x)(197.7x)27.7x
EV/EBIT18.0x228.5x(23.8x)(65.0x)34.9x
EV/Gross Profit4.0x5.6x10.3x6.6x4.6x
P/E19.4xn/m(26.9x)(87.7x)35.3x
EV/FCF24.0x(23.6x)(30.8x)(39.3x)n/m

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Biome Australia Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Biome Australia Margins & Growth Rates

Biome Australia grew revenue by 39% and EBITDA by 507% in the last fiscal year.

In the most recent fiscal year, Biome Australia reported gross margin of 61%, EBITDA margin of 3%, and net margin of 1%.

See estimated margins and future growth rates for Biome Australia

Biome Australia Margins

Last FY202420252026202720282029
Gross Margin61%61%62%62%
EBITDA Margin3%(2%)10%19%
EBIT Margin1%(6%)8%18%
Net Margin1%(5%)8%17%
FCF Margin(14%)(10%)(0%)14%

Biome Australia Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth39%55%40%41%
Gross Profit Growth42%57%42%41%
EBITDA Growth507%(84%)(814%)162%
EBIT Growth1207%(63%)(286%)208%
Net Profit Growth1484%(69%)(348%)199%
FCF Growth(205%)(21%)(93%)(4020%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Biome Australia Operational KPIs

Biome Australia's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.3M for the same period.

Biome Australia's Rule of 40 is 60% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Biome Australia's Rule of X is 122% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Biome Australia
LTMLast FY202320242025202620272028
Rule of 4058%60%---
Bessemer Rule of X122%122%---
Revenue per Employee-$0.4M---
Opex per Employee-$0.3M---
S&M Expenses to Revenue33%37%28%23%29%
G&A Expenses to Revenue-34%52%40%28%
Opex to Revenue-61%86%67%51%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Biome Australia Competitors

Biome Australia competitors include Hofseth BioCare, Provexis, Enzymatica, Valbiotis, Hyundai Bioland Co, Cosmos Health, Mycodern, Simris Group, Bio Essence and 7FIT.

Most Biome Australia public comparables operate across Nutraceuticals & Cosmeceuticals.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Hofseth BioCare2.9x-(10.3x)-
Provexis17.7x-(50.7x)-
Enzymatica10.4x10.4x(12.6x)-
Valbiotis19.5x8.8x(2.0x)(2.1x)
Hyundai Bioland Co0.8x-5.7x-
Cosmos Health0.5x-(2.1x)-
Mycodern(4301.7x)-277.7x-
Simris Group77.7x-(8.7x)-

This data is available for Pro users. Sign up to see all Biome Australia competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Biome Australia

When was Biome Australia founded?Biome Australia was founded in 2018.
Where is Biome Australia headquartered?Biome Australia is headquartered in Australia.
How many employees does Biome Australia have?As of today, Biome Australia has over 30 employees.
Is Biome Australia publicly listed?Yes, Biome Australia is a public company listed on Australian Securities Exchange.
What is the stock symbol of Biome Australia?Biome Australia trades under BIO ticker.
When did Biome Australia go public?Biome Australia went public in 2021.
Who are competitors of Biome Australia?Biome Australia main competitors include Hofseth BioCare, Provexis, Enzymatica, Valbiotis, Hyundai Bioland Co, Cosmos Health, Mycodern, Simris Group, Bio Essence, 7FIT.
What is the current market cap of Biome Australia?Biome Australia's current market cap is $45M.
What is the current revenue of Biome Australia?Biome Australia's last 12 months revenue is $18M.
What is the current revenue growth of Biome Australia?Biome Australia revenue growth (NTM/LTM) is 43%.
What is the current EV/Revenue multiple of Biome Australia?Current revenue multiple of Biome Australia is 2.5x.
What is the current EBITDA of Biome Australia?Biome Australia's last 12 months EBITDA is $3M.
What is Biome Australia's EBITDA margin?Biome Australia's last 12 months EBITDA margin is 15%.
What is the current EV/EBITDA multiple of Biome Australia?Current EBITDA multiple of Biome Australia is 16.6x.
What is the current FCF of Biome Australia?Biome Australia's last 12 months FCF is $2M.
What is Biome Australia's FCF margin?Biome Australia's last 12 months FCF margin is 10%.
What is the current EV/FCF multiple of Biome Australia?Current FCF multiple of Biome Australia is 24.0x.
How many companies Biome Australia has acquired to date?Biome Australia hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Biome Australia has invested to date?Biome Australia hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Biome Australia

Lists including Biome Australia

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial